Ther. 2019 ,27, 710–728. [CrossRef] 120. Li, M.; Li, Y.; Li, S.; Jia, L.; Wang, H.; Li, M.; Deng, J.; Zhu, A.; Ma, L.; Li, W.; et al. The Nano Delivery Systems and Applications of mRNA. Eur. J. Med. Chem. 2022 ,227, 113910. [CrossRef] 121. Liu, W.; Tang, H.; Li, L.; Wang, X.; Yu, Z.; Li, J. Peptide-Based Therapeutic Cancer Vaccine: Current Trends in Clinical Application. Cell Prolif. 2021 ,54, e13025. [CrossRef] 122. Chen, X.; Yang, J.; Wang, L.; Liu, B. Personalized Neoantigen Vaccination with Synthetic Long Peptides: Recent Advances and Future Perspectives. Theranostics 2020 ,10, 6011–6023. [CrossRef] 123. Purcell, A.W.; McCluskey, J.; Rossjohn, J. More than One Reason to Rethink the Use of Peptides in Vaccine Design. Nat. Rev. Drug Discov. 2007 ,6, 404–414. [CrossRef] [PubMed] 124. Bijker, M.S.; van den Eeden, S.J.F.; Franken, K.L.; Melief, C.J.M.; Offringa, R.; van der Burg, S.H. CD8+ CTL Priming by Exact Peptide Epitopes in Incomplete Freund’s Adjuvant Induces a Vanishing CTL Response, Whereas Long Peptides Induce Sustained CTL Reactivity. J.